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Elderly patients show increased incidence of multiple organ dysfunction in acute pancreatitis possibly due to bacterial
translocation. This is associated with increased susceptibility to infections in older people. Several reports have related this
increased susceptibility to a proinﬂammatory status called inﬂammaging, which decreases the capacity of the immunological
system to respond to antigens. Cellular senescence also contributes to this low-grade chronic inﬂammation in older subjects.
We discuss here the eﬀect of ageing on systemic inﬂammation, focusing on that induced by acute pancreatitis and some of the
mechanisms involved. It is important to understand the immunological changes in the elderly to adjust treatment strategies
in order to reduce the morbidity and mortality associated with acute pancreatitis and other conditions that lead to systemic
inﬂammation.
1.Introduction
Several reports investigating ageing physiopathology have
stated that old age is followed by a low-grade inﬂammatory
process[1],whichmaybeupregulatedduringsepsis,surgical
procedures, and ischaemic/reperfusion injury. This low-
grade inﬂammatory state is called inﬂammaging, ac o n c e p t
supportedbyseveralreports[2–4].Thisisprobablyrelatedto
antigenicstressthroughoutlifethatmayhavecausedexhaus-
tion of immunological cells, thus decreasing the capacity
of the immunological system to respond to antigens [5]. A
concept that has been established is one of senescent cells
being able to secrete many factors including growth factors,
proteases, and cytokines that can induce inﬂammation [6].
Cellular senescence is a situation where the cell has an
irreversible proliferative arrest due to potential oncogenic
stress. This cellular state, limited to proliferative cells, has
been recognized as a tumour suppressive mechanism. Senes-
cent cells remain metabolically active, producing an array
of tumour-suppressing and proinﬂammatory substances.
Senescent cells probably contribute to the chronic inﬂam-
matory state related to ageing. This subject was extensively
discussed in two important reviews, which also analyzed the
molecularmechanismsandcellularpathwaysassociatedwith
cellular senescence [6, 7].
There is also clear evidence that elderly patients are
more susceptible to infections after surgical procedures
than young patients, and this could be related to the pro-
inﬂammatory status of the elderly patients. This increased
susceptibility to infections could be the reason for the
increased postoperative morbidity and mortality observed
in elderly patients [8]. However, there are reports showing
that selection and appropriate care make the outcome of
even major surgical procedures in elderly patients similar to
that in young patients [9–15]. Thus, it seems that multiple
factorsinﬂuencethepostoperativeoutcomeofageingpeople,
including comorbidities and immunological status. It is
therefore important to understand the immunological char-
acteristic changes in the elderly to adjust treatment strategies
in order to reduce the morbidity and mortality associated2 International Journal of Inﬂammation
with surgery, infection, and acute pancreatitis (AP) among
other conditions that induce systemic inﬂammation.
2.MolecularMechanismsof
Age-Related Inﬂammation
The molecular mechanisms involved in the chronic low-
grade inﬂammation of elderly people are poorly understood.
Up- or downregulation of genes related to the development
of inﬂammation may be involved in the process. A recent
report pointed to the potential role of the poly(ADP-
ribose) polymerase-1 gene in inﬂammation and the ageing
process [16]. It has also been found that aged animals with
sepsis present higher splenic tissue concentration of alpha-
2A adrenergic receptors and phosphodiesterases (related to
the autonomic nervous system) and increased CD14 and
toll-like receptor-4 expression (related to innate immunity)
when compared to young animals. The authors of this
report concluded that hyperinﬂammation in older animals
is related not only to the innate immune response but also
to the upregulation of the adrenergic autonomic nervous
system that may contribute to increased proinﬂammatory
cytokine production [17].
The heat shock protein 70 has been shown to modulate
the systemic response of an aged host to sepsis, preventing
gut cell apoptosis and systemic inﬂammation [18]. In a study
of partial liver ischaemia/reperfusion injury, the recruited
neutrophils from aged rats were observed to have a higher-
activation statewhencompared tothose fromyounganimals
and that the hepatic heat shock protein 70 was less expressed
in old animals [19]. It is possible to speculate that the
diminished expression of heat shock protein 70 in the elderly
population may be responsible for the higher-bacterial
translocation and organ dysfunction observed in elderly
patients with AP [20].
3. SystemicInﬂammation andAgeing
Systemic inﬂammation such as that induced by sepsis is
accompanied by a burst in the production of proinﬂam-
matory cytokines, whose serum levels are higher in elderly
patients compared to the young [21].
Elderly patients usually develop an exaggerated inﬂam-
matory response after surgery and this has been attributed to
the proinﬂammatory status of older people [22]. However,
when pro-inﬂammatory cytokine levels are analyzed, con-
tradictory reports are found in the literature: (a) increased
and delayed levels of interleukin (IL)-6 have been observed
inelderlypatientsaftersurgery[23];(b)monocyteactivation
and hypercytokinemia have been observed in elderly patients
after surgical intervention [24]; (c) signiﬁcantly higher
levels of tumour necrosis factor (TNF)-alpha, IL-6, and
IL-1-beta are produced by mitogen-stimulated peripheral
mononuclear cells from the elderly when compared to young
subjects [19]. Contrarily, blood monocytes from elderly
patients with pneumonia produce less proinﬂammatory
cytokines (IL-1beta, TNF-alpha, and IL-8) upon stimulation
than those from young patients [25]. The controversy is
further increased by reports showing that young and old
patients with community-acquired pneumonia [26]h a v e
similar serum levels of IL-6 and IL-10, and that there is
no diﬀerence in serum pro-inﬂammatory cytokine levels
between elderly and young patients after coronary surgery.
Ischaemia/reperfusion is another condition that induces
systemic inﬂammation. Liver ischaemic/reperfusion injury
is increased in older animals due to an exaggerated pro-
duction of TNF-alpha. Inhibition of TNF-alpha produc-
tion reverses the eﬀect of ageing in ischaemic/reperfusion
injury [27]. Ischaemic preconditioning protects young livers
from ischaemic/reperfusion injury; however, this strategy
increases liver damage in old livers [27]. This information is
extremely important for liver surgeons dealing with hepatic
ischaemia.
It is important to consider that during systemic inﬂam-
mation, organ-speciﬁc alterations may take place and con-
tribute to systemic inﬂammation. The lungs are particularly
aﬀected, which release a second wave of mediators that may
potentiate systemic inﬂammation. In an experimental model
of systemic inﬂammation, it was found that lung injury was
much more intense in aged compared to young mice, as
demonstrated by increased inducible nitric oxide synthase
expression and decreased extracellular superoxide dismutase
levels [28].
4.AcutePancreatitisandAgeing
Severe AP is associated with high morbidity and mortality
due to local pancreatic complications and multiple organ
dysfunction [29, 30]. Although the mortality rate of severe
AP has decreased in recent years, it is still around 20 to 25%
[31, 32].
Advanced age has been considered an independent
prognostic factor for mortality in AP [33]. The presence
of complications such as infected pancreatic necrosis in the
aged population is associated with a mortality rate of up
to 50% [34]. In elderly patients with AP, in spite of similar
occurrence of local complications, a substantial increase in
multiple organ failure has been found [20]. However, it has
not been clearly demonstrated that elderly patients with AP
have diﬀerent outcomes when compared to younger patients
[35, 36]. Despite the severity of local inﬂammation being
higher in younger compared to older patients, the score that
measures the clinical severity of the disease (APACHE II,
acute physiology, and chronic health evaluation) is higher
in elderly patients [35]. To our understanding, this indicates
that the severity of systemic response in elderly patients is
more intense.
Although ageing is related to increased mortality due to
organ failure in AP, no diﬀerences in local complications
between young and elderly patients have been observed
[37, 38]. Indeed, advanced age and associated diseases do
not inﬂuence the occurrence of pancreatic necrosis [39]. The
factors related to the increased incidence of organ failure
in elderly patients, however, are not well understood and
may be related to changes in the innate immune system
or to an abnormal elevation of proinﬂammatory cytokinesInternational Journal of Inﬂammation 3
Table 1: Eﬀect of ageing on acute pancreatic inﬂammation.
Young Elderly references
Mortality ↑↑ ↑[33]
Organ failure ↑↑ ↑[20]
Local complications ↑↑ [37, 38]
Bacterial translocation ↑↑ ↑ ∗
Systemic inﬂammation ↑↑ ↑[35]
∗Coelho AMM, Machado MCC, Sampietre SN et al. Aging is related to
increased intestinal damage and bacterial translocation in acute pancreatitis
in rats (in preparation).
in the bowel, which facilitates bacterial translocation. In a
recent study, we found that 2-year-old rats with taurocholic
acid-induced AP presented much higher-bacterial translo-
cation than the young ones (in preparation). The available
information on the eﬀect of ageing on AP inﬂammation is
summarized in Table 1.
5. FutureStudiesand Conclusions
Studies addressing intestinal alterations during AP in older
animals should help to elucidate the mechanisms involved
in bacterial translocation that are related to multiple organ
failure in AP.
New strategies that reduce the exaggerated inﬂammatory
response in elderly patients are needed to decrease morbidity
and mortality in elderly patients with AP. Our group
has shown some strategies that reduce the inﬂammatory
response in experimental AP, such as lavage of the peritoneal
cavity [40], treatment with hypertonic saline solution [41,
42], treatment with platelet-activating factor antagonists
[43], and pentoxifylline [44]. It would be desirable to
investigate if these strategies are also eﬀective in reducing the
exaggeratedinﬂammatoryresponseinolderanimalswithAP.
Specialized diets have been proposed to increase innate
immunity and protect elderly patients from infections and
should also be tested in elderly AP patients [45].
In conclusion, advanced age is considered an indepen-
dent prognostic factorfor mortality in acutepancreatitis, but
the mechanisms involved in this process are not completely
understood. Organ failure seems to be the most important
factor responsible for the higher mortality rate observed in
elderlypatientssincelocalcomplicationsaresimilarinyoung
and older patients.
It is conceivable that diﬀerent therapeutic strategies
should be employed in young and old people to control AP,
and clinical trials on anti-inﬂammatory and antimicrobial
drugs in AP should consider patient age as an important
issue.
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